Endurant Capital Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,984
| Closed | -$906K | – | 16 |
|
|
2023
Q4 | $906K | Buy |
+3,984
| New | +$837K | 5.19% | 6 |
|
|
2023
Q3 | – | Sell |
-37,910
| Closed | -$7.86M | – | 51 |
|
|
2023
Q2 | $7.86M | Sell |
37,910
-14,749
| -28% | -$2.86M | 6.86% | 3 |
|
|
2023
Q1 | $10.4M | Sell |
52,659
-53,177
| -50% | -$10.9M | 5.33% | 5 |
|
|
2022
Q4 | $21.4M | Sell |
105,836
-7,357
| -6% | -$1.44M | 8.69% | 2 |
|
|
2022
Q3 | $19.9M | Buy |
113,193
+72,781
| +180% | +$14.9M | 6.49% | 2 |
|
|
2022
Q2 | $8.14M | Sell |
40,412
-30,917
| -43% | -$6.59M | 2.85% | 12 |
|
|
2022
Q1 | $16.2M | Sell |
71,329
-4,764
| -6% | -$1.12M | 4.26% | 4 |
|
|
2021
Q4 | $20.5M | Buy |
76,093
+54,176
| +247% | +$13.4M | 4.96% | 4 |
|
|
2021
Q3 | $5.3M | Sell |
21,917
-51,321
| -70% | -$12.9M | 1.21% | 24 |
|
|
2021
Q2 | $17.4M | Buy |
73,238
+20,597
| +39% | +$4.69M | 4.77% | 2 |
|
|
2021
Q1 | $11.5M | Buy |
52,641
+29,554
| +128% | +$5.93M | 3.01% | 10 |
|
|
2020
Q4 | $4.04M | Buy |
+23,087
| New | +$3.99M | 1.46% | 27 |
|
|
2020
Q3 | – | Sell |
-44,133
| Closed | -$6.3M | – | 67 |
|
|
2020
Q2 | $6.3M | Buy |
44,133
+13,469
| +44% | +$1.86M | 0.35% | 15 |
|
|
2020
Q1 | $3.33M | Sell |
30,664
-95,098
| -76% | -$13.7M | 1.51% | 18 |
|
|
2019
Q4 | $18.3M | Buy |
125,762
+22,186
| +21% | +$3.2M | 5.76% | 6 |
|
|
2019
Q3 | $14.9M | Buy |
103,576
+7,080
| +7% | +$1.03M | 5.37% | 6 |
|
|
2019
Q2 | $14.3M | Buy |
96,496
+44,268
| +85% | +$6.18M | 5.65% | 2 |
|
|
2019
Q1 | $6.86M | Buy |
+52,228
| New | +$6.43M | 2.71% | 16 |
|
|
2018
Q3 | – | Sell |
-1,454
| Closed | -$224K | – | 80 |
|
|
2018
Q2 | $224K | Sell |
1,454
-32,971
| -96% | -$4.98M | 0.1% | 64 |
|
|
2018
Q1 | $4.78M | Buy |
34,425
+10,476
| +44% | +$1.54M | 1.79% | 20 |
|
|
2017
Q4 | $3.28M | Buy |
+23,949
| New | +$3.16M | 1% | 38 |
|
|
2017
Q3 | – | Sell |
-8,395
| Closed | -$1.11M | – | 96 |
|
|
2017
Q2 | $1.11M | Sell |
8,395
-15,248
| -64% | -$1.87M | 0.31% | 63 |
|
|
2017
Q1 | $2.91M | Buy |
23,643
+10,941
| +86% | +$1.3M | 0.94% | 37 |
|
|
2016
Q4 | $1.4M | Sell |
12,702
-21,301
| -63% | -$2.37M | 0.58% | 47 |
|
|
2016
Q3 | $4.02M | Sell |
34,003
-21,185
| -38% | -$2.5M | 1.49% | 24 |
|
|
2016
Q2 | $6.18M | Buy |
55,188
+8,148
| +17% | +$877K | 2.06% | 16 |
|
|
2016
Q1 | $4.73M | Buy |
47,040
+12,339
| +36% | +$1.18M | 1.53% | 27 |
|
|
2015
Q4 | $3.69M | Sell |
34,701
-4,866
| -12% | -$502K | 1.23% | 31 |
|
|
2015
Q3 | $3.69M | Sell |
39,567
-96,612
| -71% | -$9.99M | 1.23% | 31 |
|
|
2015
Q2 | $14.2M | Buy |
136,179
+67,629
| +99% | +$7.04M | 4.19% | 3 |
|
|
2015
Q1 | $7.43M | Sell |
68,550
-16,063
| -19% | -$1.65M | 2.45% | 8 |
|
|
2014
Q4 | $7.84M | Buy |
+84,613
| New | +$7.47M | 3.08% | 8 |
|
Other funds holding LH
Endurant Capital Management's LH Position: Q1 2024 in Review
Endurant Capital Management sold out of Labcorp (LH) in Q1 2024, closing a stake of 3,984 shares — an estimated $906K sold.
Endurant Capital Management first reported a position in LH in Q4 2014 and held it in 32 quarters. The position peaked at $21.4M in Q4 2022. 928 funds tracked by Wall St. Rank hold LH as of Q1 2024.
- Endurant Capital Management reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
- Endurant Capital Management sold 3,984 Labcorp shares in Q1 2024, an estimated $906K.
- Endurant Capital Management first reported a position in Labcorp in Q4 2014 and held it in 32 quarters.
- Endurant Capital Management's Labcorp position peaked at $21.4M in Q4 2022.
- 928 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.
Based on Endurant Capital Management's 13F filing for Q1 2024.